Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurodegenerative Diseases

• Publication date

  2011-05-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000325829PMID 21576919
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropsychological Features of Patients with Spinocerebellar Ataxia (SCA) Types 1, 2, 3, and 6

  2010cited by this paper
• Social and clinical determinants of quality of life in Parkinson’s disease in Austria: a cohort study

  2010cited by this paper
• Social and clinical determinants of quality of life in Parkinson's disease in a Russian cohort study.

  2010cited by this paper
• Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease

  2010cited by this paper
• A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy

  2010cited by this paper
• Costs of Parkinson's disease in eastern Europe: a Czech cohort study.

  2010cited by this paper
• Incidence of Parkinson's disease and atypical parkinsonism: Russian population‐based study

  2010cited by this paper
• Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy

  2010cited by this paper
• Costs of Parkinson’s Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study

  2010cited by this paper
• [Comparison of quality of life in multiple system atrophy and Parkinson's disease].

  2009cited by this paper
• Multiple system atrophy: an update.

  2009cited by this paper
• A comprehensive model of health-related quality of life in Parkinson’s disease

  2008cited by this paper
• Quality of life in Parkinson's disease: The relative importance of the symptoms

  2008cited by this paper
• Duodenal Levodopa Infusion Improves Quality of Life in Advanced Parkinson’s Disease

  2008cited by this paper
• Subjective Quality of Life in Psychiatric Patients: Diagnosis and Illness-Specific Profiles

  2008cited by this paper
• Measuring health‐related quality of life in MSA: The MSA‐QoL

  2007cited by this paper
• Determinants of quality of life in Brazilian patients with Parkinson's disease

  2007cited by this paper
• Testing the validity of the PDQ-39 in patients with MSA.

  2007cited by this paper
• Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross‐sectional study in Croatia

  2007cited by this paper
• Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study.

  2007cited by this paper
• Health‐related quality of life in multiple system atrophy

  2006cited by this paper
• Measuring quality of life in PSP

  2006cited by this paper
• [Health Status of the German population: results of a representative survey using the EuroQol questionnaire].

  2005cited by this paper
• Validating the EQ-5D with time trade off for the German population

  2005cited by this paper
• Depressive symptoms and life satisfaction in patients with multiple system atrophy

  2005cited by this paper
• Gesundheitszustand der deutschen Bevölkerung: Ergebnisse einer repräsentativen Befragung mit dem EuroQol-Instrument

  2005cited by this paper
• Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)

  2004cited by this paper
• Health‐related quality of life in patients with progressive supranuclear palsy

  2003cited by this paper
• Epidemiology of multiple system atrophy

  2001cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2001cited by this paper
• The EQ-5 D — a generic quality of life measure — is a useful instrument to measure quality of life in patients with Parkinson ’ s disease

  2000cited by this paper
• The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson's disease

  2000cited by this paper
• Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.

  1999influential reference
• Consensus statement on the diagnosis of multiple system atrophy.

  1999cited by this paper
• Parkinsonism

  1998cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy

  1998cited by this paper
• Measuring treatment outcome by the Beck Depression Inventory.

  1997cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Parkinsonism

  1967cited by this paper
• An inventory for measuring depression.

  1961cited by this paper

• Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment

  2025cites this paper
• Impact of rehabilitation on quality of life in patients with degenerative cerebellar ataxias using structural equation modeling

  2025cites this paper
• MeDeMSA care study protocol: developing personalized best medical care with integrated mobile palliative and telemedicine support for individuals with multiple system atrophy.

  2025cites this paper
• Health related quality of life (HRQOL) from the perspective of patients with chronic whiplash-associated disorders (WAD) in Sweden

  2025cites this paper
• Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET

  2024cites this paper
• Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review

  2024cites this paper
• Determinants of care partner burden in atypical Parkinsonian syndromes: A retrospective, multi-center analysis

  2024cites this paper
• Progressive Supranuclear palsy (PSP) disease progression, management, and healthcare resource utilization: a retrospective observational study in the US and Canada

  2024cites this paper
• Characterizing the individual course of health-related quality of life after subarachnoid haemorrhage: Latent growth mixture modelling.

  2023cites this paper
• Neurological update: the palliative care landscape for atypical parkinsonian syndromes

  2023cites this paper
• Magnetic resonance imaging in the diagnosis of progressive supranuclear palsy: A case report and review of literature

  2023cites this paper
• Pitolisant-supported bridging during drug holidays to deal with tolerance to modafinil in patients with narcolepsy.

  2023cites this paper
• Pain in Multiple System Atrophy a Systematic Review and Meta‐Analysis

  2023cites this paper
• Patient-perceived progression in multiple system atrophy: natural history of quality of life

  2023cites this paper
• Screening for health-related quality of life and its determinants in Fabry disease: A cross-sectional multicenter study.

  2023cites this paper
• Neurological update: non-motor symptoms in atypical parkinsonian syndromes

  2023cites this paper
• Pathomechanisms of depression in progressive supranuclear palsy

  2023cites this paper
• Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson’s disease

  2022cites this paper
• PDQ-8: A Simplified and Effective Tool Measuring Life Quality in Progressive Supranuclear Palsy

  2022influential citation
• Patients’ Perspective in Hereditary Ataxia

  2022cites this paper
• Factors impacting quality of life in multiple system atrophy

  2022cites this paper
• Pathomechanisms of depression in multiple system atrophy

  2022cites this paper
• Health‐related quality of life in patients with multiple system atrophy using the EQ‐5D‐5L

  2022influential citation
• Depression in multiple system atrophy: Views on pathological, clinical and imaging aspects

  2022cites this paper
• Imaging correlates of depression in progressive supranuclear palsy

  2022cites this paper
• A case report of Multi System Atrophy (MSA) with cross over features of Progressive Supranuclear Palsy (PSP)

  2021cites this paper
• Pain in neurodegenerative diseases with atypical parkinsonism: a systematic review on prevalence, clinical presentation, and findings from experimental studies.

  2021cites this paper
• Health-related quality of life in multiple system atrophy using EQ-5D-5L: a large cross-sectional study in China

  2021cites this paper
• Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsy

  2021cites this paper
• Cerebrolysin in the therapy of mild cognitive impairment and dementia due to Alzheimer's disease: 30 years of clinical use

  2020cites this paper
• Prediagnostic motor and non-motor symptoms in progressive supranuclear palsy: The step-back PSP study.

  2020cites this paper
• The Profile and Evolution of Neuropsychiatric Symptoms in Multiple System Atrophy: Self- and Caregiver Report.

  2020cites this paper
• Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.

  2019cites this paper
• Frontal lobe function, behavioral changes and quality of life in patients with multiple system atrophy

  2019cites this paper
• Factors associated with deterioration of health-related quality of life in multiple system atrophy: 1-year follow-up study

  2018influential citation
• Health-related quality of life in patients with poststroke epilepsy

  2018cites this paper
• Genetic analysis of multiple system atrophy and related movement disorders

  2018cites this paper
• Clinical characteristics and quality of life in Chinese patients with multiple system atrophy

  2018cites this paper
• Neuropsychiatric disturbances in atypical parkinsonian disorders

  2018cites this paper
• Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis

  2018cites this paper
• Neuropsychiatric disturbances in atypical parkinsonian disorders

  2018cites this paper
• Neuropsychiatric disturbances in atypical parkinsonian disorders

  2018cites this paper
• Depression and anxiety in multiple system atrophy

  2018cites this paper
• Present and future of disease-modifying therapies in multiple system atrophy.

  2018cites this paper
• Nonmotor Features in Atypical Parkinsonism.

  2017cites this paper
• Quality of life and palliative care need in multiple system atrophy and progressive supranuclear palsy : a pilot study using quantitative and qualitative methods

  2017cites this paper
• Multiple System Atrophy: Clinical, Genetics, and Neuropathology

  2017cites this paper
• Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.

  2017cites this paper
• Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy.

  2017cites this paper
• Pain in Extrapyramidal Neurodegenerative Diseases

  2017cites this paper
• Effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review

  2016cites this paper
• Scales to Assess Clinical Features of Progressive Supranuclear Palsy: MDS Task Force Report

  2015cites this paper
• Quality of life in patients with progressive supranuclear palsy: one-year follow-up

  2015cites this paper
• Dysphagia in spinocerebellar ataxia and multiple system atrophy-cerebellar

  2015influential citation
• Dementia in Parkinson’s Disease and Atypical Parkinsonism

  2014cites this paper
• Challenges Faced by Patients With Progressive Supranuclear Palsy and their Families

  2014cites this paper
• Quality of life in outpatients with depression in China.

  2013cites this paper
• Individual and Societal Impact

  2013cites this paper
• Schmerzwahrnehmung und Schmerzempfindung bei Progressiver Supranukleärer Blickparese (PSP)

  2013cites this paper
• Clinical determinants of health-related quality of life in Mexican patients with Parkinson's disease.

  2013cites this paper
• Functional impairment in progressive supranuclear palsy

  2013cites this paper
• Assessment of quality of life with the multiple system atrophy health‐related quality of life scale

  2012cites this paper
• Clinical pain and experimental pain sensitivity in progressive supranuclear palsy.

  2012cites this paper
• Preliminary Study of Intravenous Amantadine Treatment for Ataxia Management in Patients with Probable Multiple System Atrophy with Predominant Cerebellar Ataxia

  2012cites this paper
• Health-Related Quality of Life and its Determinants in the Urban Russian Population with Major Depressive Disorder: A Cross-Sectional Study

  2012cites this paper
• Contents Vol. 8, 2011

  2011cites this paper